You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 145 No. 6, June 1985 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL INVESTIGATIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on Web of Science (35)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Plasma Norepinephrine, Epinephrine, and Dopamine Levels in End-Stage Renal Disease

Effect of Hemodialysis

Alan N. Elias, MD; Nosratola D. Vaziri, MD; Magdy Maksy, MD

Arch Intern Med. 1985;145(6):1013-1015.


Abstract

• The effect of hemodialysis on plasma norepinephrine (NE), epinephrine, and dopamine levels was studied in 11 patients undergoing maintenance hemodialysis. The results showed that the baseline plasma concentrations of NE and dopamine were significantly elevated in patients with end-stage renal disease undergoing maintenance hemodialysis. Intradialysis weight loss and fall in the serum glucose concentration during dialysis correlated with changes in plasma epinephrine and NE concentrations. Single-pass dialysis resulted in a marked reduction in the plasma NE concentration, indicating significant removal by dialysis. These observations should be taken into consideration when interpreting plasma catecholamine data obtained in the course of investigation of hypertensive patients with end-stage renal disease.

(Arch Intern Med 1985;145:1013-1015)



Author Affiliations

From the Divisions of Endocrinology (Dr Elias) and Nephrology (Drs Vaziri and Maksy), Department of Medicine, University of California, Irvine, Medical Center.


Footnotes

Accepted for publication Oct 18, 1984.

Reprint requests to Division of Endocrinology, University of California, Irvine, Medical Center, 101 City Dr S, Orange, CA 92668 (Dr Elias).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Norepinephrine and Concentric Hypertrophy in Patients With End-Stage Renal Disease
Zoccali et al.
Hypertension 2002;40:41-46.
ABSTRACT | FULL TEXT  

Plasma Norepinephrine Predicts Survival and Incident Cardiovascular Events in Patients With End-Stage Renal Disease
Zoccali et al.
Circulation 2002;105:1354-1359.
ABSTRACT | FULL TEXT  

Left Ventricular Response to Exercise and Autonomic Control Mechanisms in End-Stage Renal Disease
Blake et al.
Arch Intern Med 1989;149:433-436.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1985 American Medical Association. All Rights Reserved.